Development of Adverse Outcome Pathways module for immunotoxicity of per, poly-fluoroalkyl substances through exploration of the mechanisms behind suppression of vaccine-induced antibody response. Immunological work related to cell culture, animal experimentation, field studies in the areas of PFAS exposure.
ECHS invites applications to engage following Medical, Para Medical & non med staff on contractual basis in ECHS Polyclinic Bhuj. B.Pharma from a recognised Institute.
Sterile operation, Microbiology with quality management system understanding. Internal audits with updation in current guidelines. CAPA management and effective implementation.
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.
Monitoring for Documents compilation activities for New product filing , Re-Registration, renewals from plant dossier filing , sample requirements etc. Participation in Action plan discussion for queries from different Regulatory agencies and monitoring for submission of data, documents from plant.
Advantmed helps health plans and providers improve their risk adjustment, quality improvement, and health assessment programs with market-leading accuracy, flexibility, and transparency.
After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.